Gut Compound Implicated in Higher Alzheimer's Disease Risk

New research published in Nature Communications suggests that imidazole propionate (ImP), a compound produced by gut bacteria, may heighten the risk of Alzheimer's disease. The study indicates ImP contributes to brain changes associated with Alzheimer's and related dementias. This discovery opens avenues for potentially targeting ImP to prevent or slow the progression of the neurodegenerative disease.